Goldman Sachs Group Inc Harvard Bioscience Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 175,424 shares of HBIO stock, worth $375,407. This represents 0.0% of its overall portfolio holdings.

Number of Shares
175,424
Previous 77,834 125.38%
Holding current value
$375,407
Previous $221,000 113.12%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$2.64 - $3.54 $257,637 - $345,468
97,590 Added 125.38%
175,424 $471,000
Q2 2024

Aug 13, 2024
BUY
$2.77 - $4.63 $104,994 - $175,495
37,904 Added 94.93%
77,834 $221,000
Q1 2024

May 15, 2024
SELL
$4.02 - $5.39 $1,382 - $1,854
-344 Reduced 0.85%
39,930 $169,000
Q4 2023

Feb 13, 2024
BUY
$4.0 - $5.49 $39,572 - $54,312
9,893 Added 32.56%
40,274 $215,000
Q3 2023

May 14, 2024
SELL
$4.0 - $5.82 $39,572 - $57,577
-9,893 Reduced 24.56%
30,381 $130,000
Q3 2023

Nov 14, 2023
SELL
$4.0 - $5.82 $66,580 - $96,873
-16,645 Reduced 35.4%
30,381 $130,000
Q2 2023

May 14, 2024
BUY
$4.19 - $6.16 $41,631 - $61,205
9,936 Added 26.79%
47,026 $258,000
Q2 2023

Aug 14, 2023
BUY
$4.19 - $6.16 $41,631 - $61,205
9,936 Added 26.79%
47,026 $258,000
Q1 2023

May 14, 2024
BUY
$2.45 - $4.22 $59,623 - $102,697
24,336 Added 190.81%
37,090 $155,000
Q1 2023

May 11, 2023
BUY
$2.45 - $4.22 $59,623 - $102,697
24,336 Added 190.81%
37,090 $155,000
Q4 2022

May 14, 2024
SELL
$2.12 - $2.86 $51,687 - $69,729
-24,381 Reduced 65.66%
12,754 $35,000
Q4 2022

Feb 13, 2023
SELL
$2.12 - $2.86 $51,687 - $69,729
-24,381 Reduced 65.66%
12,754 $35,000
Q3 2022

May 14, 2024
SELL
$2.33 - $3.92 $60,307 - $101,461
-25,883 Reduced 41.07%
37,135 $95,000
Q3 2022

Nov 10, 2022
SELL
$2.33 - $3.92 $60,307 - $101,461
-25,883 Reduced 41.07%
37,135 $0
Q2 2022

May 14, 2024
BUY
$3.28 - $6.42 $74,600 - $146,016
22,744 Added 56.47%
63,018 $227,000
Q2 2022

Aug 15, 2022
SELL
$3.28 - $6.42 $100,755 - $197,209
-30,718 Reduced 32.77%
63,018 $227,000
Q1 2022

May 16, 2022
SELL
$5.16 - $7.14 $19,927 - $27,574
-3,862 Reduced 3.96%
93,736 $583,000
Q4 2021

Feb 14, 2022
SELL
$6.37 - $8.18 $19,129 - $24,564
-3,003 Reduced 2.99%
97,598 $688,000
Q3 2021

Nov 10, 2021
BUY
$6.98 - $8.47 $702,194 - $852,090
100,601 New
100,601 $702,000

Others Institutions Holding HBIO

# of Institutions
97
Shares Held
30.6M
Call Options Held
700
Put Options Held
2.1K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email